Creating patient lifetime value across therapy areas

Bio Merieux logo
Customers CSL logo
Customers Novo logo
Sanofi logo
Claritas rx logo
Rhapsody logo
Xealth logo
Woebot logo
Cooley logo
Eclipse logo
Flex logo
FPT logo
General Catalyst logo
Global Logic Hitachi logo
Google cloud logo
Guidea logo
Guidepoint logo
Health XL logo
Insight partners logo
New Leaf Venture logo
Rare Patient Voice logo
Schlesinger logo
Shapiro Raj vertical logo
Slalom logo

Build, scale, and optimize personal, multi-modal experiences that support patients across their care journey

BrightInsight is the patient persistence solution that predicts and prevents therapy drop-off — before it happens. Our solution unifies the patient experience, detects the behavioral signals that precede discontinuation, and triggers the right intervention at the moments that matter most. The result: patients who stay on therapy longer, and brands that reclaim the revenue their science was built to generate.

Learn more

With fewer than 1 in 3 patients still on a novel therapy at 12 months, the persistence crisis steals health from patients and $500B+ in annual value from brands every year

BrightInsight closes the gap your existing systems were never designed to fill — unifying signals, programs, and interventions into one intelligent experience that keeps patients on therapy longer, compounding value and health outcomes into year two, year three, and beyond.

Persistence crisis desktop Persistence crisis mobile
Learn more

News

See how we reduced discontinuation by 4% and boosted adherence by 4% in one year for Sanofi.

Learn more
Sanofi case study image

Featured in

Logo nasdaq
Logo hlth
Logo yahoo finance
Logo medtech dive
Logo global news wire
Logo pharmaphorum
Logo forbes
Logo cision
Logo frost sullivan
Logo cioreview

Recent insights

Let’s keep your patients on life-changing therapy

Contact us today to start a conversation about how we can help turn your greatest revenue leak into your most powerful growth lever.

Contact us